Loading...
XTSX
AVCR
Market cap4mUSD
Dec 05, Last price  
0.06CAD
1D
20.00%
1Q
-7.69%
Jan 2017
-72.73%
IPO
-85.00%
Name

Avricore Health Inc

Chart & Performance

D1W1MN
XTSX:AVCR chart
P/E
P/S
1.27
EPS
Div Yield, %
Shrs. gr., 5y
16.23%
Rev. gr., 5y
170.57%
Revenues
5m
+37.32%
223,586256,243249,042282,2611,459,686305,59283,36183,36183,3615,713156,4671,013,690537,714226,44533,00033,030122,8081,768,3743,485,1474,785,711
Net income
-669k
L-4.60%
-378,301-562,090-1,937,735-1,183,009-3,992,659-1,875,565-306,565283,432-733,946-2,200,648-2,819,719-2,613,904-3,486,324-5,391,654-2,112,848-1,332,918-1,746,570-826,597-701,215-668,977
CFO
1m
+52.12%
-314,656-371,023-876,722-930,623-3,612,059-673,340-58,663-154,607-539,519-1,484,577-1,927,590-2,064,090-1,767,296-1,725,047-686,407-1,223,396-1,234,154-437,832660,4031,004,615

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Avricore Health Inc. engages in the health data and point-of-care technologies business in Canada. It provides HealthTab, a lab-accurate point of care testing platform for pharmacy. The company has strategic partnerships with Shoppers Drug Marts and Abbott. The company was formerly known as Vanc Pharmaceuticals Inc. and changed its name to Avricore Health Inc. in October 2018. Avricore Health Inc. was founded in 1996 and is based in Vancouver, Canada.
IPO date
Jul 31, 2001
Employees
Domiciled in
CA
Incorporated in
CA

Valuation

Title
CAD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT